Latest Breaking News On - Asdq listing rule 5646c 4 - Page 1 : comparemela.com

LAWRENCEVILLE, N.J., June 26, 2023 (GLOBE NEWSWIRE) Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company focused on DNA-based.

Jeffreyw churchImunon incExchange commissionCompensation committeeNasdaq listing ruleInducement option grantsInducement option grantInducement stock grantsPrivate securities litigation reform actVice presidentNasdaq imnnNasdaq imnnClinical stageDrug development companyInducement option grantsAsdq listing rule 5646c 4